VERACYTE INC (VCYT) Stock Fundamental Analysis
NASDAQ:VCYT - Nasdaq - US92337F1075 - Common Stock - Currency: USD
Taking everything into account, VCYT scores 6 out of 10 in our fundamental rating. VCYT was compared to 571 industry peers in the Biotechnology industry. While VCYT has a great health rating, its profitability is only average at the moment. VCYT is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make VCYT a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year VCYT was profitable.
In the past year VCYT had a positive cash flow from operations.
In the past 5 years VCYT reported 4 times negative net income.
In multiple years VCYT reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.86%, VCYT belongs to the top of the industry, outperforming 92.82% of the companies in the same industry.
VCYT's Return On Equity of 2.05% is amongst the best of the industry. VCYT outperforms 93.52% of its industry peers.
VCYT's Return On Invested Capital of 1.26% is amongst the best of the industry. VCYT outperforms 93.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.86% | ||
| ROE | 2.05% | ||
| ROIC | 1.26% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 5.41%, VCYT belongs to the best of the industry, outperforming 93.87% of the companies in the same industry.
With an excellent Operating Margin value of 4.38%, VCYT belongs to the best of the industry, outperforming 94.05% of the companies in the same industry.
The Gross Margin of VCYT (67.54%) is better than 81.26% of its industry peers.
VCYT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.38% | ||
| PM (TTM) | 5.41% | ||
| GM | 67.54% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VCYT is destroying value.
Compared to 1 year ago, VCYT has more shares outstanding
Compared to 5 years ago, VCYT has more shares outstanding
There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 12.54 indicates that VCYT is not in any danger for bankruptcy at the moment.
VCYT has a better Altman-Z score (12.54) than 90.37% of its industry peers.
VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.54 |
ROIC/WACC0.14
WACC9.16%
2.3 Liquidity
A Current Ratio of 4.73 indicates that VCYT has no problem at all paying its short term obligations.
With a Current ratio value of 4.73, VCYT perfoms like the industry average, outperforming 52.54% of the companies in the same industry.
VCYT has a Quick Ratio of 4.46. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of VCYT (4.46) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.73 | ||
| Quick Ratio | 4.46 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 129.13% over the past year.
Looking at the last year, VCYT shows a very strong growth in Revenue. The Revenue has grown by 23.46%.
Measured over the past years, VCYT shows a very strong growth in Revenue. The Revenue has been growing by 29.93% on average per year.
EPS 1Y (TTM)129.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%115.38%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%20.81%
3.2 Future
Based on estimates for the next years, VCYT will show a very strong growth in Earnings Per Share. The EPS will grow by 53.20% on average per year.
Based on estimates for the next years, VCYT will show a quite strong growth in Revenue. The Revenue will grow by 8.73% on average per year.
EPS Next Y83.17%
EPS Next 2Y70.33%
EPS Next 3Y68.22%
EPS Next 5Y53.2%
Revenue Next Year10.11%
Revenue Next 2Y10.57%
Revenue Next 3Y10.16%
Revenue Next 5Y8.73%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 107.30, which means the current valuation is very expensive for VCYT.
Compared to the rest of the industry, the Price/Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 92.47% of the companies listed in the same industry.
VCYT is valuated expensively when we compare the Price/Earnings ratio to 29.71, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 58.58, which means the current valuation is very expensive for VCYT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.42% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of VCYT to the average of the S&P500 Index (22.34), we can say VCYT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 107.3 | ||
| Fwd PE | 58.58 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VCYT is valued cheaper than 93.87% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 94.57% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.1 | ||
| EV/EBITDA | 51.54 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VCYT has a very decent profitability rating, which may justify a higher PE ratio.
VCYT's earnings are expected to grow with 68.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.29
PEG (5Y)N/A
EPS Next 2Y70.33%
EPS Next 3Y68.22%
5. Dividend
5.1 Amount
VCYT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:VCYT (3/6/2025, 2:08:58 PM)
32.19
-0.77 (-2.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners103.95%
Inst Owner Change-1.47%
Ins Owners0.58%
Ins Owner Change-1.06%
Market Cap2.49B
Analysts82.22
Price Target47.23 (46.72%)
Short Float %4.07%
Short Ratio3.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)265.28%
Min EPS beat(2)-48.53%
Max EPS beat(2)579.09%
EPS beat(4)3
Avg EPS beat(4)285.14%
Min EPS beat(4)-48.53%
Max EPS beat(4)579.09%
EPS beat(8)5
Avg EPS beat(8)87.38%
EPS beat(12)9
Avg EPS beat(12)73.22%
EPS beat(16)12
Avg EPS beat(16)58%
Revenue beat(2)1
Avg Revenue beat(2)1.52%
Min Revenue beat(2)-0.39%
Max Revenue beat(2)3.44%
Revenue beat(4)3
Avg Revenue beat(4)4.15%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)11.88%
Revenue beat(8)7
Avg Revenue beat(8)4.89%
Revenue beat(12)11
Avg Revenue beat(12)5.61%
Revenue beat(16)15
Avg Revenue beat(16)6.6%
PT rev (1m)3.82%
PT rev (3m)7.44%
EPS NQ rev (1m)-4.77%
EPS NQ rev (3m)-1.64%
EPS NY rev (1m)0%
EPS NY rev (3m)22.44%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 107.3 | ||
| Fwd PE | 58.58 | ||
| P/S | 5.6 | ||
| P/FCF | 39.1 | ||
| P/OCF | 33.22 | ||
| P/B | 2.12 | ||
| P/tB | 7.61 | ||
| EV/EBITDA | 51.54 |
EPS(TTM)0.3
EY0.93%
EPS(NY)0.55
Fwd EY1.71%
FCF(TTM)0.82
FCFY2.56%
OCF(TTM)0.97
OCFY3.01%
SpS5.75
BVpS15.17
TBVpS4.23
PEG (NY)1.29
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.86% | ||
| ROE | 2.05% | ||
| ROCE | 1.6% | ||
| ROIC | 1.26% | ||
| ROICexc | 1.65% | ||
| ROICexgc | 18.38% | ||
| OM | 4.38% | ||
| PM (TTM) | 5.41% | ||
| GM | 67.54% | ||
| FCFM | 14.31% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score7
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 48.11% | ||
| Cap/Sales | 2.53% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 174.77% | ||
| Profit Quality | 264.35% | ||
| Current Ratio | 4.73 | ||
| Quick Ratio | 4.46 | ||
| Altman-Z | 12.54 |
F-Score7
WACC9.16%
ROIC/WACC0.14
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)129.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%115.38%
EPS Next Y83.17%
EPS Next 2Y70.33%
EPS Next 3Y68.22%
EPS Next 5Y53.2%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%20.81%
Revenue Next Year10.11%
Revenue Next 2Y10.57%
Revenue Next 3Y10.16%
Revenue Next 5Y8.73%
EBIT growth 1Y211.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year193.28%
EBIT Next 3Y71.28%
EBIT Next 5Y55.14%
FCF growth 1Y86.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.82%
OCF growth 3YN/A
OCF growth 5YN/A